CX3CL1 and Parkinson disease: In this group, we observed a severe reduction in CX3CL1 immunopositive neurons as well as a reduction in CX3CL1 immunofluorescence intensity, which was similar to what was seen in the PD group, indicating that downregulation of CX3CL1 is an early event.